Plavix and Invanz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Plavix (clopidogrel bisulfate) and Invanz (ertapenem sodium). Common drug interactions include hepatitis among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Plavix and Invanz. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,179 Plavix users. Check the latest studies of Plavix.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.



On Aug, 09, 2026

41 people who take Plavix and Invanz together, and have interactions are studied.

Plavix and Invanz drug interactions.

What are the common drug interactions of Plavix and Invanz, by gender? *:

female:

  1. Hepatitis (inflammation of the liver)
  2. Hypotension (abnormally low blood pressure)
  3. Immunosuppressant drug level decreased
  4. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  5. Prothrombin time shortened
  6. Rash
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)

male:

  1. Fall
  2. Anaemia (lack of blood)
  3. Coagulation time prolonged
  4. Haematuria (presence of blood in urine)
  5. Hypotension (abnormally low blood pressure)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Abdominal pain
  8. Abdominal tenderness
  9. Acute respiratory distress syndrome
  10. Agitation (state of anxiety or nervous excitement)

What are the common drug interactions of Plavix and Invanz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abasia (inability to walk)
  2. Asthenia (weakness)
  3. Dysarthria (speech disorder)

30-39:

n/a

40-49:

  1. Spinal compression fracture (fracture due to spinal compression on bone)
  2. Arthralgia (joint pain)
  3. Cardiomegaly (increased size of heart than normal)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Diaphragmatic hernia (defect or hole in the diaphragm that allows the abdominal contents to move into the chest cavity)
  6. Gastric haemorrhage (bleeding stomach)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Pneumonia
  9. Rib fracture

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Confusional state
  3. Hallucination (an experience involving the perception of something not present)
  4. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  5. Psychotic disorder
  6. Pyrexia (fever)
  7. Restlessness (not able to rest)
  8. Dysstasia (difficulty in standing)
  9. Fall
  10. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
  2. Fall
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Pyrexia (fever)
  5. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  6. Coagulation time prolonged
  7. Haematuria (presence of blood in urine)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Abdominal pain
  10. Abdominal tenderness

What are the existing conditions these people have? *

  1. Pain: 4 people, 9.76%
  2. Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 7.32%
  3. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 7.32%
  4. Osteomyelitis (infection of bone): 3 people, 7.32%
  5. Cellulitis (infection under the skin): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Plavix and Invanz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Plavix and Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plavix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invanz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate and ertapenem sodium (the active ingredients of Plavix and Invanz, respectively), and Plavix and Invanz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: